Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 154 (ZNF154) is a DNA-binding transcription factor of the Kruppel family, implicated in transcriptional regulation via zinc finger domains[2][8]. It acts as a tumor suppressor in epithelial-derived cancers, with promoter hypermethylation leading to its silencing and tumor progression[1]. ZNF154 directly regulates genes involved in proliferation, migration, and tumor suppression, notably through pathways such as cell cycle control and p53/Wnt signaling[1]. Reactivation of ZNF154 by epigenetic editing (e.g., CRISPR/dCas9-Tet1 or 5-aza-dC) restores its tumor suppressive functions, highlights its value as both a biomarker and therapeutic target in cancer[1][2][8].
Epigenetic modulation (e.g., demethylation of promoter regions restores ZNF154 expression and inhibits tumor cell proliferation/migration; drugs like 5-aza-dC promote re-expression)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 154 (ZNF154).